Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Eckman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pediatric Blood & Cancer|July 19, 2019
Characterizing complication risk from multisite, intermittent transfusions for the treatment of sickle cell diseaseAmy Tang, Jane Branscomb, Mei Zhou, et al.
American Journal of Hematology|September 28, 2010
Leg ulcers in sickle cell diseaseCaterina P Minniti, James Eckman, Paola Sebastiani, et al.
Public Health Reports (Washington, D.C. : 1974)|April 11, 2019
Improving an Administrative Case Definition for Longitudinal Surveillance of Sickle Cell DiseaseAngela B Snyder, Mei Zhou, Rodney Theodore, et al.
Pediatric Blood & Cancer|May 4, 2024
Immunization adherence among children with sickle cell disease and sickle cell trait: Results of a population-based studyJiajing Scarlette Shi, Ankit Sutaria, Sangeetha Lakshmanan, et al.
Contemporary Clinical Trials|January 20, 2023
Sickle Cell Trevor Thompson Transition Project (ST3P-UP) protocol for managing care transitions: Methods and rationaleIfeyinwa Osunkwo, Raymona Lawrence, Myra Robinson, et al.
American Journal of Hematology|November 21, 2008
Sickle cell disease summit: from clinical and research disparity to actionKathryn Hassell, Betty Pace, Winfred Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myelomaNizar J Bahlis, Jennifer McCafferty-Grad, Ileana Jordan-McMurry, et al.
British Journal of Haematology|January 20, 2007
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell diseaseElliott Vichinsky, Onyinye Onyekwere, John Porter, et al.
JAMA|April 4, 2003
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatmentMartin H Steinberg, Franca Barton, Oswaldo Castro, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pediatric Blood & Cancer|July 19, 2019
Characterizing complication risk from multisite, intermittent transfusions for the treatment of sickle cell diseaseAmy Tang, Jane Branscomb, Mei Zhou, et al.
American Journal of Hematology|September 28, 2010
Leg ulcers in sickle cell diseaseCaterina P Minniti, James Eckman, Paola Sebastiani, et al.
Public Health Reports (Washington, D.C. : 1974)|April 11, 2019
Improving an Administrative Case Definition for Longitudinal Surveillance of Sickle Cell DiseaseAngela B Snyder, Mei Zhou, Rodney Theodore, et al.
Pediatric Blood & Cancer|May 4, 2024
Immunization adherence among children with sickle cell disease and sickle cell trait: Results of a population-based studyJiajing Scarlette Shi, Ankit Sutaria, Sangeetha Lakshmanan, et al.
Contemporary Clinical Trials|January 20, 2023
Sickle Cell Trevor Thompson Transition Project (ST3P-UP) protocol for managing care transitions: Methods and rationaleIfeyinwa Osunkwo, Raymona Lawrence, Myra Robinson, et al.
American Journal of Hematology|November 21, 2008
Sickle cell disease summit: from clinical and research disparity to actionKathryn Hassell, Betty Pace, Winfred Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myelomaNizar J Bahlis, Jennifer McCafferty-Grad, Ileana Jordan-McMurry, et al.
British Journal of Haematology|January 20, 2007
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell diseaseElliott Vichinsky, Onyinye Onyekwere, John Porter, et al.
JAMA|April 4, 2003
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatmentMartin H Steinberg, Franca Barton, Oswaldo Castro, et al.
Pageof 1